Related Experiment Videos
[Acute intermittent porphyria coexisting with chronic postinfectious renal failure]
Anna Szymańska-Chabowska1, Anna Skoczyńska, Ewa Chlebda
1Katedra i Klinika Chorób Wewnetrznych, Zawodowych i Nadciśnienia Tetniczego AM we Wrocławiu.
Polskie Archiwum Medycyny Wewnetrznej
|January 29, 2005
Summary
This case study details a 46-year-old woman with acute intermittent porphyria (AIP) who developed chronic renal failure and died despite treatment. Skin lesions suggest a possible, unconfirmed conversion to variegate porphyria (VP).
Area of Science:
- Nephrology
- Genetics
- Dermatology
Background:
- Acute intermittent porphyria (AIP) is a rare genetic disorder affecting the heme biosynthesis pathway.
- Complications of AIP can include neurological and renal dysfunction.
- Autonomic neuropathy is a recognized, though less common, complication of AIP.
Observation:
- A 46-year-old woman with a history of AIP presented with progressive chronic renal failure.
- Her renal failure was attributed to hypertension, recurrent urinary tract infections, and a neurogenic bladder secondary to autonomic neuropathy.
- The patient's condition deteriorated, leading to death despite undergoing hemodialysis.
Findings:
- The development of chronic renal failure in this AIP patient highlights the potential for severe systemic complications.
- The appearance of skin lesions in the terminal stage raised a hypothesis regarding a possible conversion of AIP to variegate porphyria (VP).
- This conversion hypothesis remains speculative due to the absence of definitive enzymatic laboratory tests.
Implications:
- This case underscores the importance of vigilant monitoring for systemic complications in AIP patients, including renal and neurological issues.
- The potential for AIP to evolve into VP, suggested by skin manifestations, warrants further investigation and the development of diagnostic tools.
- Understanding such rare disease progressions is crucial for refining patient management strategies and improving outcomes in porphyria disorders.